Industry-Sponsored Symposium - A Clinical Overview of a Prescription Treatment for Patients With Moderately to Severely Active Ulcerative Colitis

Asher Kornbluth, MD

This program is sponsored by Pfizer.

Dr. Kornbluth will discuss the clinical data and safety profile of a prescription treatment for adult patients with moderately to severely active ulcerative colitis.

Open to all ACG 2022 attendees, industry-sponsored symposia provide additional educational opportunities. These programs are independent of the ACG 2022 Annual Scientific Meeting and Postgraduate Course programs. ACG is not the continuing medical education provider of these programs. For more information, see the company sponsor.